The global atopic dermatitis treatment market is projected to grow at a considerable CAGR of around 6% during the forecast period (2020-2026). Genes and outer environment are the two factors responsible for the atopic dermatitis disorder. According to the National Institute of Allergy and Infectious Diseases, atopic dermatitis is an inflammatory skin condition that affects nearly 30% of the US population, mostly children and adolescents. The high prevalence of atopic disorder is a key factor driving the growth of the market across the globe.